Sven Hobbie und Ceo Of Juvabis - Info zur Person

(1 - 8 von 8

)

Juvabis causes a stir with new antibiotic - Startupticker.ch

www.startupticker.ch

— ... and clearly support our commitment to progressing the clinical development of EBL-1003,” said Dr. Sven Hobbie, CEO of Juvabis. › news

AMR - Q by Mediaplanet UK&IE - Issuu

issuu.com

— But, as Dr Sven Hobbie, Founding CEO of Juvabis points out, “For life-threatening infections common also in Europe, like Acinetobacter ... › mediaplanetuk › docs

Juvabis Announces Positive Phase 1 Results of EBL in ...

biocom.de

— EBL-1003,” said Dr. Sven Hobbie, CEO of Juvabis. “Several studies, both our own and those by independent researchers, have demonstrated the ... › › IMM_PR_EBL-1003

AMR Centre attends the 10th Berlin Conference on Life Sciences ...

www.infextx.com

Bernd Lammel/BIOCOM AG – Dr. Peter Jackson presenting the winner's certificate to Sven Hobbie, CEO of Juvabis. The AMR Centre was pleased to be invited to ... › ...

Juvabis AG - Startup.ch

www.startup.ch

Dr Sven Hobbie, Founding CEO of Juvabis, announced as Top 16 candidate for the W.A. #devigier Awards. No Jobs. Videos. SCSN Player is loading. › Juvabis